HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Whitehead, S. S. Articles by Hruby, D. E. Search for Related Content PubMed PubMed Citation Articles by Whitehead, S. S. Articles by Hruby, D. E. Agricola Articles by Whitehead, S. S. Articles by Hruby, D. E.

Physical and molecular genetic analysis of the multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein

Center for Gene Research and Biotechnology, Department of Microbiology, Oregon State University, Corvallis, OR 97331-3804, USA

Three potential AG*X cleavage sites have previously been identified in vaccinia virus (VV) P4a precursor, namely AG*N, AG*S and AG*T. Utilization of the COOH-proximal AG*T site in P4a leads to release of a 23 kDa product (‘23K’). Here we propose that cleavage at the AG*S site alone is responsible for release of 4a, based on peptide mapping and microsequencing which demonstrated that the NH₂ terminus of 4a is co-terminal with P4a, thus indicating that the AG*N site is excluded from proteolytic processing. Proteolysis of P4a at AG*S and AG*T to yield 4a and 23K should theoretically also liberate an intervening 9 kDa peptide (‘9K’), although efforts to isolate this peptide have been repeatedly unsuccessful. To investigate the fate of this intervening peptide, mutation of the P4a coding sequence at the AG*S or AG*T site, followed by transient expression in VV-infected cells, lead to the synthesis of unique 4a-9K or 9K–23K chimeric protein products. This implies that neither end of the intervening 9K peptide is intrinsically destabilizing, and that its supposed degradation may be suppressed when it remains associated with 4a or 23K.

^* Author for correspondence. Mailing address: M6 Pharmaceuticals Inc., 200 Corporate Blvd South, Yonkers, NY 10701, USA. Fax +1 914 476 6798. e-mail 73172.3212@compuserve.com

Received 22 August 1994; accepted 4 November 1994.

This article has been cited by other articles:

				W.-L. Chiu and W. Chang Vaccinia Virus J1R Protein: a Viral Membrane Protein That Is Essential for Virion Morphogenesis J. Virol., October 1, 2002; 76(19): 9575 - 9587. [Abstract] [Full Text] [PDF]

				C. M. Byrd, T. C. Bolken, and D. E. Hruby The Vaccinia Virus I7L Gene Product Is The Core Protein Proteinase J. Virol., September 1, 2002; 76(17): 8973 - 8976. [Abstract] [Full Text] [PDF]

				J.-J. Hung, C.-S. Chung, and W. Chang Molecular Chaperone Hsp90 Is Important for Vaccinia Virus Growth in Cells J. Virol., February 1, 2002; 76(3): 1379 - 1390. [Abstract] [Full Text] [PDF]

				R. Heljasvaara, D. Rodriguez, C. Risco, J. L. Carrascosa, M. Esteban, and J. R. Rodriguez The Major Core Protein P4a (A10L Gene) of Vaccinia Virus Is Essential for Correct Assembly of Viral DNA into the Nucleoprotein Complex To Form Immature Viral Particles J. Virol., July 1, 2001; 75(13): 5778 - 5795. [Abstract] [Full Text] [PDF]